Infant protection from invasive <i>Haemophilus influenzae</i> type b disease using the PRP-OMPC conjugate vaccine: An update. [PDF]
Taha MK +5 more
europepmc +1 more source
Microbiological treatment failure associated with macrolide-resistant <i>Bordetella pertussis</i>. [PDF]
Prabhakar D +10 more
europepmc +1 more source
The effect of preexisting antibodies from Tdap vaccination during pregnancy on infant antibody responses to the pertussis-containing vaccines. [PDF]
Sereeyothin C +4 more
europepmc +1 more source
The Bordetella pertussis protein Pertactin: role in immunity and immune evasion
Pertussis is a highly contagious infectious disease of the respiratory tract which is caused by Bordetella pertussis. Before widespread introduction of vaccination against pertussis, almost every child contracted pertussis. The disease is most severe in neonates and children under the age of 1.
openaire +1 more source
Antibody waning and Bordetella pertussis resurgence after the COVID-19 pandemic in the Netherlands. [PDF]
Gaasbeek CM +10 more
europepmc +1 more source
Macrolide-resistant Bordetella pertussis strain identified during an ongoing epidemic, Finland, January to October 2024. [PDF]
Miettinen M +7 more
europepmc +1 more source
Type 5 secretion system antigens as vaccines against Gram-negative bacterial infections. [PDF]
Da Costa RM +4 more
europepmc +1 more source
Mechanisms of natural and vaccine-induced immunity to Bordetella pertussis. [PDF]
Borkner L +4 more
europepmc +1 more source

